drug discovery

Changing the Industry: Thrive Global’s Interview with Dr. Michael Shuler

by

We have set out on a journey to change the drug development process for the better so patients can get the treatments they desperately need and not have to wait years for them to become available. Michael L. Shuler Hesperos’ CEO and Co-Founder, Dr. Michael Shuler, was recently interviewed by Jason Hartman with Thrive Global … Read more

Dr. Hickman Presents Human-on-a-Chip® at Florida Simulation Summit 2020

by
human-on-a-chip

Presentation Highlights

This is a company overview presentation given by Dr. James Hickman at this years Florida Simulation Summit 2020 in October.  Learn more about the technology and exciting path ahead. Key highlights from the presentation include:

  • A brief history of Hesperos
  • How the Human-on-a-Chip technology works and the current state of the technology
  • Key applications and path forward

Human-on-a-Chip®

Functional in vitro models that accurately predict how new drug candidates will impact the human body – something that has previously required animal testing or human clinical trials to determine.

What’s on each Chip?

Systemic toxicology models with interlinked organs, including: heart, liver, lung, brain, skin, muscle, GI tract, kidney, pancreas, endocrine, bone marrow and the neuromuscular junction in a serum free, recirculating medium utilizing a pumpless platform.

ALS pathology investigated by UCF/Hesperos Researchers Utilizing a Human-on-a-Chip® model

by
als

UCF/HESPEROS RESEARCHERS UTILIZE HUMAN-ON-A-CHIP® APPROACH TO MODEL ALS PATHOLOGY Key Findings Data supports use of functional neuromuscular junction (NMJ) system to evaluate amyotrophic lateral sclerosis pathology  First study to validate the use of Deanna protocol in a human system as a strategy for treating ALS  Press Release  ORLANDO, Fla. — The Hybrid Systems Lab at … Read more

NIH Director Features HESPEROS BODY-ON-A-CHIP DEVICE for predicting CANCER DRUG RESPONSES

by

Dr. Francis Collins, director of The National Institutes of Health, recently featured Hesperos technology on his blog. In the post, Dr. Collins reviews a published study where Hesperos researchers investigated and treated several cancer lines with existing chemotherapeutics.  The study both treated the cancer while reproducing known toxic effects of specific drugs and their more … Read more